Halvorsen Buys Amazon, Sells Out Micron Technology During Q2

Most weighted trades include Google, Walgreens, Illumina

Author's Avatar
Oct 05, 2015
Article's Main Image

Andreas Halvorsen (Trades, Portfolio) is a founding partner of Viking Global Investors LP, which is a global investment firm founded in 1999 and has offices in Greenwich, N.Y., Hong Kong and London and is registered as an investment adviser with the U.S. Securities and Exchange Commission.

He manages a portfolio composed of 56 stocks with a total value of $26.47 billion and during the last quarter he increased 20 stakes and reduced 19 of them, bought 18 new stocks and sold out 19 of his existing stakes. The following are the most weighted of the above trades.

Halvorsen bought 2,282,561 shares of Amazon.com Inc. (AMZN) with an impact of 3.74% on his portfolio.

It is an online retailer; it sells its products through its website. It also provides services such as advertising services and co-branded credit card agreements. It operates in two geographical segments: North America and International.

Amazon reported the second quarter with increased operating cash flow of 69% and an increase of 20% for net sales increased compared to the same quarter of a year before. During Q2, it opened Amazon Mexico and launched Prime free same-day.

The stock is trading with a forward P/E ratio of 89.29 and has been as high as $580.57 and as low as $284.00 in the past year. It is currently 10.31% below its 52-week high and 83.35% above its 52-week low.

Chris Davis (Trades, Portfolio) is the main shareholder of the company with 0.96% of outstanding shares, followed by Ken Fisher (Trades, Portfolio) with 0.53% and Jeremy Grantham (Trades, Portfolio) with 0.53%.

He sold out shares of Mondelez International Inc. (MDLZ) with an impact of 3.35% on his portfolio.

It manufactures and markets confectionery products. The company manufactures and markets food and beverage products for consumers in approximately 165 countries around the world. Its portfolio includes nine billion-dollar brands.

Driven by record net productivity, during the last quarter, adjusted gross margin increased 330 basis points, to 40.2%. The strong year-to-date results reflect clear progress in the execution of their transformation agenda.

The stock is trading with a P/E ratio of 33.35 and has been as high as $48.58 and as low as $31.83 in the past year. It is currently 13.11% below its 52-week high and 32.61% above its 52-week low. According to the DCF calculator, the company currently looks overpriced by 127%.

Bill Ackman (Trades, Portfolio) is the main shareholder of the company with 7.46% of outstanding shares, followed by Pioneer Investments (Trades, Portfolio) and First Eagle Investment (Trades, Portfolio) with 0.24%.

He sold out shares of Micron Technology Inc. (MU) with an impact of 3.27% on his portfolio.

The company manufactures and markets a range of DRAM, NAND Flash and NOR Flash memory as well as other memory technologies, packaging solutions and semiconductor systems for use in computing, consumer, networking, automotive, industrial, embedded and mobile products.

The company reported the last quarter with 7% decrease for revenues compared a quarter before and 15% lower compared to the same quarter of a year before. Even so these fourth-quarter results were impacted by continued weakness in the PC sector, but MU believes that memory industry fundamentals remain favorable over the long term.

The stock is trading with a P/E ratio of 4.95 and has been as high as $36.59 and as low as $13.50 in the past year. It is currently 59.63% below its 52-week high and 9.41% above its 52-week low. According to the DCF calculator, the company currently looks undervalued by 67%.

The main hedge fund of the company is PRIMECAP Management (Trades, Portfolio) with 3.51% of outstanding shares, followed by David Einhorn (Trades, Portfolio) with 3.50%, Seth Klarman (Trades, Portfolio) with 1.82% and Donald Smith (Trades, Portfolio) with 1.41%.

He increased his stake in Walgreens Boots Alliance Inc. (WBA) by 68.83% and with an impact of 3.20% on his portfolio.

The company together with its subsidiaries operates drug stores in the United States. The company provides consumer goods and services, pharmacy and health and wellness services in communities across America. It also offers products and services through drugstores, as well as through mail, telephone, online and mobile application.

During the fiscal 3Q 2015, adjusted net earnings per diluted share increased 22.9%, and sales increased 48.4%. During this quarter the company increased fiscal 2015 full year adjusted net earnings guidance to $3.70 to $3.80 per diluted share.

The stock is trading with a P/E ratio of 22.71 and has been as high as $97.30 and as low as $58.52 in the past year. It is currently 13.02% below its 52-week high and 44.62% above its 52-week low. According to the DCF calculator, the company currently looks overpriced by 105%.

Andreas Halvorsen (Trades, Portfolio) is the main shareholder of the company with 2.25% of outstanding shares, followed by Jana Partners (Trades, Portfolio) with 1.26% and Vanguard Health Care Fund (Trades, Portfolio) with 0.70%.

He reduced his stake in Illumina Inc. (ILMN)by 41.59% with an impact of 2.55% on his portfolio.

The company provides sequencing- and array-based solutions for genetic analysis. Its products enabled researchers to explore DNA, helping them create the first map of gene variations associated with health, disease and drug response.

For the second quarter of the year, revenue had a 21% increase compared to the same quarter of a year before, also gross margin in the second quarter of 2015 was 69.8% compared to 67.1% in the prior year period.

The stock is trading with a P/E ratio of 48.09 and has been as high as $242.37 and as low as $145.12 in the past year. It is currently 35.14% below its 52-week high and 8.33% above its 52-week low. According to the DCF calculator, the company currently looks overpriced by 226%.

Steve Mandel (Trades, Portfolio) is the main hedge fund of the company with 3.92% of outstanding shares, followed by Andreas Halvorsen (Trades, Portfolio) with 3.43% and Frank Sands (Trades, Portfolio) with 1.83%.

He bought 4,769,014 shares of Avago Technologies Ltd. (AVGO) with an impact of 2.39% on his portfolio.

The company is a designer, developer and global supplier of various analog semiconductor devices with a focus on III-V based products. Its primary target markets are wireless communications, wired infrastructure, industrial and automotive electronics and consumer and computing peripherals.

The company reported the third quarter fiscal year 2015 with quarterly GAAP gross margin of 51% and non-GAAP gross margin from continuing operations of 61%.

The stock is trading with a P/E ratio of 32.10 and has been as high as $150.50 and as low as $68.75 in the past year. It is currently 18.84% below its 52-week high and 77.66% above its 52-week low. According to the DCF calculator, the company currently looks overpriced by 120%.

The main shareholder is Andreas Halvorsen (Trades, Portfolio) with 1.73% of outstanding shares, followed by Lee Ainslie (Trades, Portfolio) with 0.78% and Meridian Funds (Trades, Portfolio) with 0.42%.

He increased his stake in Google Inc. (GOOGL)by 67% and with an impact of 2.24% on his portfolio.

The company is a technology company engaged in improving the ways people connect with information. The company's business is mainly around the following areas: search, display advertising, operating systems and platforms, enterprise and hardware products.

During the last quarter, revenue growth was 11% year over year; constant currency revenue growth was 18% year over year. These strong results reflect continued growth across the breadth of their products, most notably core search.

The stock is trading with a P/E ratio of 30.42 and has been as high as $713.33 and as low as $490.91 in the past year. It is currently 10.00% below its 52-week high and 30.78% above its 52-week low. According to the DCF calculator, the company currently looks overpriced by 13%.

Even here, Halvorsen is the main shareholder of the company with 0.40% of outstanding shares, followed by PRIMECAP Management (Trades, Portfolio) with 0.39% and Frank Sands (Trades, Portfolio) with 0.31%.